Literature DB >> 1008060

Tay-Sachs screening: motives for participating and knowledge of genetics and probability.

B Childs, L Gordis, M M Kaback, H H Kazazian.   

Abstract

A highly-educated, socially aware group of persons presented themselves for Tay-Sachs screening having learned about it mainly from friends, newspapers, radio, and television but not from physicians or rabbis. After learning that screening was possible and deciding that it is in principle a good idea, and after discussing it with relatives and friends but not with physicians and rabbis, they presented themselves for the test. Although the participants knew that Tay-Sachs is a serious disease and that Jews are vulnerable, few of them knew much about the genetics of the disease, its frequency, or the incidence of the carrier state. This experience of screening for Tay-Sachs carriers suggests the need for physicians to learn the relation of genetics to preventive medicine, and for the public to learn more about the biology of man.

Entities:  

Mesh:

Year:  1976        PMID: 1008060      PMCID: PMC1685190     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  6 in total

1.  Advocacy and compliance in genetic screening. Behavior of physicians and clients in a voluntary program of testing for the Tay-Sachs gene.

Authors:  E Beck; S Blaichman; C R Scriver; C L Clow
Journal:  N Engl J Med       Date:  1974-11-28       Impact factor: 91.245

2.  Genetic clinic. A follow-up.

Authors:  C O Carter; J A Roberts; K A Evans; A R Buck
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

3.  Patients' subjective interpretation of risks offered in genetic counselling.

Authors:  J H Pearn
Journal:  J Med Genet       Date:  1973-06       Impact factor: 6.318

Review 4.  Approaches to the control and prevention of Tay-Sachs disease.

Authors:  M M Kaback; R S Zeiger; L W Reynolds; M Sonneborn
Journal:  Prog Med Genet       Date:  1974

5.  Why people use health services.

Authors:  I M Rosenstock
Journal:  Milbank Mem Fund Q       Date:  1966-07

6.  Some influences on public participation in a genetic screening program.

Authors:  M H Becker; M M Kaback; I M Rosenstock; M V Ruth
Journal:  J Community Health       Date:  1975
  6 in total
  11 in total

1.  Tay-Sachs screening: social and psychological impact.

Authors:  B Childs; L Gordis; M M Kaback; H H Kazazian
Journal:  Am J Hum Genet       Date:  1976-11       Impact factor: 11.025

2.  PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population.

Authors:  W W Grody; C Dunkel-Schetter; Z H Tatsugawa; M A Fox; C Y Fang; R M Cantor; J M Novak; H N Bass; B F Crandall
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

3.  Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood.

Authors:  P T Rowley; L Fisher; M Lipkin
Journal:  Am J Hum Genet       Date:  1979-11       Impact factor: 11.025

4.  Obstetricians' attitudes toward genetic screening.

Authors:  L Gordis; B Childs; M G Roseman
Journal:  Am J Public Health       Date:  1977-05       Impact factor: 9.308

5.  Progress in screening for inborn errors of metabolism.

Authors:  R W Watts
Journal:  Experientia       Date:  1978-02-15

6.  Scientific and ethical consequences of disease prediction.

Authors:  M Siegler; S Amiel; J Lantos
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

7.  High school Tay-Sachs disease carrier screening: 5 to 11-year follow-up.

Authors:  Helen Curd; Sharon Lewis; Ivan Macciocca; Margaret Sahhar; Vicki Petrou; Agnes Bankier; Sari Lieberman; Ephrat Levy-Lahad; Martin B Delatycki
Journal:  J Community Genet       Date:  2013-07-27

8.  Influence of obstetricians' attitudes on their use of prenatal diagnosis for the detection of Down's syndrome.

Authors:  A Lippman-Hand; D I Cohen
Journal:  Can Med Assoc J       Date:  1980-06-21       Impact factor: 8.262

9.  Prenatal screening for hemoglobinopathies. II. Evaluation of counseling.

Authors:  S Loader; C J Sutera; M Walden; A Kozyra; P T Rowley
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

10.  Prenatal screening for hemoglobinopathies. I. A prospective regional trial.

Authors:  P T Rowley; S Loader; C J Sutera; M Walden; A Kozyra
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.